Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090249266> ?p ?o ?g. }
- W2090249266 endingPage "4083" @default.
- W2090249266 startingPage "4071" @default.
- W2090249266 abstract "A series of O(6)-allyl- and O(6)-(2-oxoalkyl)guanines were synthesized and evaluated, in comparison with the corresponding O(6)-alkylguanines, as potential inhibitors of the DNA-repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT). Simple O(6)-alkyl- and O(6)-cycloalkylguanines were weak AGT inactivators compared with O(6)-allylguanine (IC(50) = 8.5 +/- 0.6 microM) with IC(50) values ranging from 100 to 1000 microM. The introduction of substituents at C-2 of the allyl group of O(6)-allylguanine reduced activity compared with the parent compound, while analogous compounds in the O(6)-(2-oxoalkyl)guanine series exhibited very poor activity (150-1000 microM). O(6)-Cycloalkenylguanines proved to be excellent AGT inactivators, with 1-cyclobutenylmethylguanine (IC(50) = 0.55 +/- 0.02 microM) and 1-cyclopentenylmethylguanine (IC(50) = 0.39 +/- 0.04 microM) exhibiting potency approaching that of the benchmark AGT inhibitor O(6)-benzylguanine (IC(50) = 0.18 +/- 0.02 microM). 1-Cyclopentenylmethylguanine also inactivated AGT in intact HT29 human colorectal carcinoma cells (IC(50) = 0.20 +/- 0.07 microM) and potentiated the cytotoxicity of the monomethylating antitumor agent Temozolomide by approximately 3- and 10-fold, respectively, in the HT29 and Colo205 tumor cell lines. The observation that four mutant AGT enzymes resistant to O(6)-benzylguanine also proved strongly cross-resistant to 1-cyclopentenylmethylguanine indicates that the O(6)-substituent of each compound makes similar binding interactions within the active site of AGT." @default.
- W2090249266 created "2016-06-24" @default.
- W2090249266 creator A5003813316 @default.
- W2090249266 creator A5012564677 @default.
- W2090249266 creator A5013174494 @default.
- W2090249266 creator A5018749174 @default.
- W2090249266 creator A5020043621 @default.
- W2090249266 creator A5032387920 @default.
- W2090249266 creator A5037778274 @default.
- W2090249266 creator A5041800911 @default.
- W2090249266 creator A5047222821 @default.
- W2090249266 creator A5054768314 @default.
- W2090249266 creator A5062593068 @default.
- W2090249266 creator A5079667957 @default.
- W2090249266 date "2000-09-14" @default.
- W2090249266 modified "2023-10-14" @default.
- W2090249266 title "Resistance-Modifying Agents. 8. Inhibition of <i>O</i><sup>6</sup>-Alkylguanine-DNA Alkyltransferase by <i>O</i><sup>6</sup>-Alkenyl-, <i>O</i><sup>6</sup>-Cycloalkenyl-, and <i>O</i><sup>6</sup>-(2-Oxoalkyl)guanines and Potentiation of Temozolomide Cytotoxicity in Vitro by <i>O</i><sup>6</sup>-(1-Cyclopentenylmethyl)guanine" @default.
- W2090249266 cites W1971331879 @default.
- W2090249266 cites W2032152522 @default.
- W2090249266 cites W2054073363 @default.
- W2090249266 cites W2055338425 @default.
- W2090249266 cites W2068767544 @default.
- W2090249266 cites W2137304732 @default.
- W2090249266 cites W2151249535 @default.
- W2090249266 cites W2166382251 @default.
- W2090249266 cites W2167713837 @default.
- W2090249266 cites W2318985750 @default.
- W2090249266 cites W4255542107 @default.
- W2090249266 doi "https://doi.org/10.1021/jm000961o" @default.
- W2090249266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11063604" @default.
- W2090249266 hasPublicationYear "2000" @default.
- W2090249266 type Work @default.
- W2090249266 sameAs 2090249266 @default.
- W2090249266 citedByCount "43" @default.
- W2090249266 countsByYear W20902492662013 @default.
- W2090249266 countsByYear W20902492662014 @default.
- W2090249266 countsByYear W20902492662015 @default.
- W2090249266 countsByYear W20902492662016 @default.
- W2090249266 countsByYear W20902492662017 @default.
- W2090249266 countsByYear W20902492662018 @default.
- W2090249266 countsByYear W20902492662019 @default.
- W2090249266 countsByYear W20902492662020 @default.
- W2090249266 countsByYear W20902492662022 @default.
- W2090249266 countsByYear W20902492662023 @default.
- W2090249266 crossrefType "journal-article" @default.
- W2090249266 hasAuthorship W2090249266A5003813316 @default.
- W2090249266 hasAuthorship W2090249266A5012564677 @default.
- W2090249266 hasAuthorship W2090249266A5013174494 @default.
- W2090249266 hasAuthorship W2090249266A5018749174 @default.
- W2090249266 hasAuthorship W2090249266A5020043621 @default.
- W2090249266 hasAuthorship W2090249266A5032387920 @default.
- W2090249266 hasAuthorship W2090249266A5037778274 @default.
- W2090249266 hasAuthorship W2090249266A5041800911 @default.
- W2090249266 hasAuthorship W2090249266A5047222821 @default.
- W2090249266 hasAuthorship W2090249266A5054768314 @default.
- W2090249266 hasAuthorship W2090249266A5062593068 @default.
- W2090249266 hasAuthorship W2090249266A5079667957 @default.
- W2090249266 hasConcept C104317684 @default.
- W2090249266 hasConcept C109316439 @default.
- W2090249266 hasConcept C181199279 @default.
- W2090249266 hasConcept C185592680 @default.
- W2090249266 hasConcept C202751555 @default.
- W2090249266 hasConcept C2778301229 @default.
- W2090249266 hasConcept C2778689049 @default.
- W2090249266 hasConcept C2779527866 @default.
- W2090249266 hasConcept C33288867 @default.
- W2090249266 hasConcept C512185932 @default.
- W2090249266 hasConcept C54355233 @default.
- W2090249266 hasConcept C552990157 @default.
- W2090249266 hasConcept C55493867 @default.
- W2090249266 hasConcept C71240020 @default.
- W2090249266 hasConcept C81885089 @default.
- W2090249266 hasConcept C86803240 @default.
- W2090249266 hasConcept C91965660 @default.
- W2090249266 hasConceptScore W2090249266C104317684 @default.
- W2090249266 hasConceptScore W2090249266C109316439 @default.
- W2090249266 hasConceptScore W2090249266C181199279 @default.
- W2090249266 hasConceptScore W2090249266C185592680 @default.
- W2090249266 hasConceptScore W2090249266C202751555 @default.
- W2090249266 hasConceptScore W2090249266C2778301229 @default.
- W2090249266 hasConceptScore W2090249266C2778689049 @default.
- W2090249266 hasConceptScore W2090249266C2779527866 @default.
- W2090249266 hasConceptScore W2090249266C33288867 @default.
- W2090249266 hasConceptScore W2090249266C512185932 @default.
- W2090249266 hasConceptScore W2090249266C54355233 @default.
- W2090249266 hasConceptScore W2090249266C552990157 @default.
- W2090249266 hasConceptScore W2090249266C55493867 @default.
- W2090249266 hasConceptScore W2090249266C71240020 @default.
- W2090249266 hasConceptScore W2090249266C81885089 @default.
- W2090249266 hasConceptScore W2090249266C86803240 @default.
- W2090249266 hasConceptScore W2090249266C91965660 @default.
- W2090249266 hasIssue "22" @default.
- W2090249266 hasLocation W20902492661 @default.
- W2090249266 hasLocation W20902492662 @default.
- W2090249266 hasOpenAccess W2090249266 @default.
- W2090249266 hasPrimaryLocation W20902492661 @default.
- W2090249266 hasRelatedWork W1505892068 @default.
- W2090249266 hasRelatedWork W1532011022 @default.